EVAN HEWGLEY: Open Payments
NPI 1386066694 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 29 payments from 14 companies in 2025. Trend: 2023 $407 · 2024 $445 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $85 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $84 |
| PFIZER INC. | 3 | $47 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Novo Nordisk Inc | 2 | $38 |
| Corcept Therapeutics | 2 | $37 |
| Dexcom, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: XIFAXAN, VRAYLAR, VOQUEZNA, CAPLYTA, Korlym, NUCALA, QULIPTA, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
